Considerations for Migrating a Drug Product Presentation from Vial to Pre-Filled Syringe
An increasing number of pharmaceutical companies are searching for Contract Development and Manufacturing Organizations (CDMOs) that can support them in converting an existing product presentation into a different final container type.
Most often, the tech transfer required is in converting drug products from a vial into a prefilled syringe (PFS). From the patient centricity benefits to product safety enhancements, the demand for PFS treatments has skyrocketed, and CDMOs must keep up.
This whitepaper outlines the benefits of PFS transfer, the differences between glass and PFS devices, and the key engineering processes required to successfully carry out this process.
You can download the full white paper by completing the form below.